肝细胞癌(HCC)对索拉非尼耐药相关机制的研究进展
胡倍源1(综述 )覃伟1 董琼珠2 钦伦秀1,2,3△(审校)
Progress in the mechanism studies of hepatocellular carcinoma (HCC) resistance to sorafenib treatment
HU Bei-yuan1, QIN Wei1, DONG Qiong-zhu2, QIN Lun-xiu1,2,3△
复旦学报(医学版)
.
2018, (6): 884
.
DOI: 10.3969/j.issn.1672-8467.2018.06.022
